FDA expands Pfizer's COVID-19 vaccine eligibility to adolescents 12-15 years of age

Monday, May 10, 2021 10:00 PM UTC

Photo via Reuters

The US FDA announced on Monday that they have authorized the emergency use of Pfizer-BioNTech's COVID-19 vaccine for teenagers 12 through 15 years of age, making the vaccine the first to be approved for all teenagers in the United States.

“The FDA’s expansion of the emergency use authorization for the Pfizer-BioNTech COVID-19 Vaccine to include adolescents 12 through 15 years of age is a significant step in the fight against the COVID-19 pandemic,” said Acting FDA Commissioner Janet Woodcock, M.D. “Today’s action allows for a younger population to be protected from COVID-19, bringing us closer to returning to a sense of normalcy and to ending the pandemic. Parents and guardians can rest assured that the agency undertook a rigorous and thorough review of all available data, as we have with all of our COVID-19 vaccine emergency use authorizations.”

As of Monday, 1,155,085 minors (ages 16 and 17) are fully vaccinated, and in light of today's news, this number should increase more rapidly than it had been.